Tag: pulmonary embolism

flash

FLASH results demonstrate “excellent safety profile” of the FlowTriever system in...

Results of the FLASH registry demonstrate the “excellent safety profile” of the FlowTriever system (Inari Medical) in 800 “real-world” patients. This is according to...

Penumbra and Asahi Intecc partner to introduce Indigo System to Japan

Penumbra and Asahi Intecc, a Japanese medical device manufacturer, announced that they will collaborate to introduce Penumbra’s Indigo Aspiration System into the Japanese market...

Database study could open up field for catheter-directed PE treatment research

A database study titled ‘Unplanned 30-day readmissions and in-hospital outcomes for the management of submassive and massive acute pulmonary embolism: Catheter-directed versus systemic thrombolysis’...
magneto

Magneto Thrombectomy Solutions announces successful first-in-human results for treatment of pulmonary...

Magneto Thrombectomy Solutions (Magneto), a medical devices company developing thrombectomy solutions for the treatment of ischaemic stroke and pulmonary embolism, presented successful first-in-human (FIH)...

Penumbra announces the European launch of the Indigo system with Lightning...

Penumbra has announced that its Indigo aspiration system with Lightning 7 and Lightning 12 have secured CE mark and are now commercially available in...
COVID-19

Study finds increased risk of serious blood clots up to six...

A study from Sweden published by The BMJ recently finds an increased risk of deep vein thrombosis (DVT) up to three months after COVID-19 infection,...
Cordis

Cordis makes strategic investment in E2, a developer of next-generation thrombectomy...

Cordis has announced a strategic investment venture that will expand the scope of the global cardiovascular technology company into the venous thromboembolism (VTE) market...

Aidoc extends scope of AI solutions for medical imaging into the...

Aidoc, a technology company that provides artificial intelligence (AI) solutions for medical imaging, including in the cardiovascular space, is extending its services beyond the...

First patient enrolled in PEERLESS study of FlowTriever system

Inari Medical has announced that the first patient has been enrolled in PEERLESS prospective, randomised controlled trial (RCT) comparing the outcomes of patients with...

Interventional News’ top 10 most popular items of January 2022

January’s top 10 features technological advancements, with Cook Medical receiving US Food and Drug Administration (FDA) approval for new drug-eluting stents and Adept Medical...
February's

Interventional News’ top 10 most popular items of January 2022

January’s top 10 features technological advancements, with Cook Medical receiving US Food and Drug Administration (FDA) approval for new drug-eluting stents and Adept Medical...

Thrombolex announces “very exciting” interim RESCUE results

Thrombolex recently announced the results of the RESCUE trial’s prespecified interim analysis, of the first 62 evaluable patients, in a late-breaking clinical trials session...

Viz.ai launches two new AI-powered modules for pulmonary embolism and aortic...

Viz.ai has announced the US commercial launch of its AI-powered modules for pulmonary embolism and aortic disease. Debuting at VEITHsymposium 2021 (16–20 November, Orlando, USA), the...

Inari Medical announces six-month FLASH registry interim data

  Inari Medical has announced positive acute and long-term interim results from the first 500 pulmonary embolism (PE) patients enrolled in the FlowTriever outcomes registry...
EkoSonic

Positive data for the EkoSonic endovascular system presented at VIVA 2021

Boston Scientific announced positive results for the EkoSonic endovascular system (EKOS system) during a late-breaking clinical trial presentation at Vascular Interventional Advances (VIVA) 2021...

Boston Scientific initiates randomised controlled trial for the EkoSonic endovascular system

Boston Scientific has commenced enrolment in the HI-PEITHO clinical trial, a collaborative research study with the Pulmonary Embolism Response Team (PERT) Consortium and the...

Meta-analysis: IVC filters should be considered for certain patients at high...

In a recent meta-analysis, Yang Liu, Huan Lu (Henan Cancer Hospital, Zhengzhou, China), and colleagues found insufficient evidence to prove that inferior vena cava...
Indigo

EXTRACT-PE trial data confirm Indigo Aspiration system is safe and effective...

Data from the EXRACT-PE trial, published online first in the Journal of the American College of Cardiology (JACC): Cardiovascular Interventions, found that the Indigo...

Penumbra’s newest generation of Indigo aspiration system receives FDA clearance for...

Penumbra today announced US Food and Drug Administration (FDA) 510(k) clearance for expanded indication of the latest iteration of the Indigo aspiration system, Lightning...

Similar outcomes for ultrasound-assisted and standard thrombolysis in SUNSET sPE

Efthymios Avgerinos (University of Pittsburgh, Pittsburgh, USA) presented results from the SUNSET sPE trial during a late-breaking data session at this year’s Vascular Interventional...

SUNSET sPE thrombolysis trial completes enrolment phase

The “Standard versus ultrasound-assisted catheter thrombolysis for submassive pulmonary embolism” (SUNSET sPE) trial, a randomised, single-blinded clinical trial comparing ultrasound-assisted thrombolysis (USAT) to standard...
EXTRACT-PE

EXTRACT-PE an “important first study” for aspiration thrombectomy in acute PE...

Akhilesh Sista (New York, USA) talks to Interventional News at  VIVA 2019 (Vascular InterVentional Advances; 4–7 November, Las Vegas, USA) about the results of the EXTRACT-PE study, that were presented in a late-breaking...

VIVA 2019: Penumbra Indigo Aspiration system IDE trial for acute PE...

Penumbra today announced that the EXTRACT-PE trial successfully met the primary endpoints, demonstrating the safety and efficacy of the Indigo Aspiration system for aspiration...

Thrombolex announces first enrolment in early feasibility and safety study using...

Thrombolex has announced the enrolment of the first patient in their Early Feasibility and Safety Study, investigating the Bashir Endovascular Catheter for the treatment...

Thrombus dissolution with EKOS™ Acoustic Pulse Thrombolysis™ in everyday clinical practice

 At the EKOS symposium at LINC 2019, Nils Kucher (Zurich, Switzerland), Houman Jalaie (Aachen, Germany) and Mert Dumantepe (Istanbul, Turkey) share their experiences in...

BTG acquires Novate Medical

BTG has announced it has acquired Novate Medical, a medical device company focused on the prevention of pulmonary embolism in patients at high risk...

One-year OPTALYSE PE results reinforce safety and efficacy of shorter, lower...

The study results with the Ekos system (BTG) were presented at the International Society on Endovascular Therapy (ISET; 3–7 February 2018, Florida, USA). The findings...
Interventional News for specialists

BTG receives US FDA 510(k) clearance for Ekos control unit 4.0

BTG has announced that US FDA 510(k) clearance has been granted to the Ekos control unit 4.0. The Ekos system includes an ultrasonic device...

First US commercial placements of Angel catheter

Bio2 Medical has announced that the Angel catheter, a new device for the prevention of pulmonary embolism, was placed in two patients at St...